Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Washington | 1,247 Studies

Clinical Trials Breast CancerWashington

Breast Cancer Clinical Trials in Washington

Find 1,247 clinical trials for breast cancer near Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 421-440 of 1,247 trials

CompletedNodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO StudyThe purposes of this multicenter retrospective cohort study are to determine the residual nodal burden in patients with isolated tumor cells detected in the SLN or the clipped…NCT06464341·Phoenix, Arizona and 61 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingFirst in Human Study of TUB-030 in Patients With Advanced Solid TumorsThe goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030.NCT06657222·New Haven, Connecticut and 19 others

Active not recruitingA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07220060 and PF-07104091) in people with breast cancer.NCT05262400·Los Angeles, California and 43 others

CompletedHER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerRATIONALE: Vaccines made from the HER2/neu antigen may make the body build an immune response and kill tumor cells.NCT00003002·Seattle, Washington

UnknownCryoablation Therapy in Treating Patients With Invasive Ductal Breast CancerThis phase II trial is studying how well cryoablation therapy works in treating patients with invasive ductal breast cancer. Cryoablation kills tumor cells by freezing them.NCT00723294·Burbank, California and 15 others

RecruitingA Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult PatientsThe goal of this clinical trial is to compare patient-centered outcomes when screening digital breast tomosynthesis (DBT) exams are interpreted with versus without a leading…NCT06934239·Los Angeles, California and 5 others

CompletedIntensity Modulated Radiotherapy for Breast CancerThis study delivers radiation therapy to any residual breast tissue and the chest wall plus lymph node areas around the breast.NCT00594477·St Louis, Missouri

RecruitingA Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerA study to assess the efficacy and safety of Dato-DXd in the pre-chemotherapy setting for patients with metastatic HR-positive, HER2 IHC 0 breast cancer.NCT07205822·Largo, Florida and 39 others

CompletedExercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsThis pilot trial studies how well exercise intervention after cancer treatment works in improving physical activity in stage II-III breast cancer survivors.NCT03523195·Seattle, Washington

Active not recruitingClinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or PlaceboThe main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug, atezolizumab, is…NCT03281954·Mobile, Alabama and 216 others

CompletedStudy of AMG 650 in Adult Participants With Advanced Solid TumorsTo evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).NCT04293094·Los Angeles, California and 21 others

Active not recruitingDNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)NCT04567420·Tucson, Arizona and 18 others

TerminatedTrial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesThis is a multicenter, open-label, phase 1 study conducted to test intratumoral injections of TTI-621 in subjects that have relapsed and refractory percutaneously accessible solid…NCT02890368·Duarte, California and 6 others

CompletedA Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast CancerThis is a global Phase III, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy and safety of neoadjuvant treatment with atezolizumab…NCT03197935·Palo Alto, California and 67 others

CompletedSonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After PlacementThe purpose of this study is to determine how long collagen based marker clips remain visible by ultrasound after placement in suspicious breast lesions and if collagen based…NCT00548392·Seattle, Washington

Active not recruitingA Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast CancerThis phase II trial tests whether \[18F\]FluorThanatrace by positron emission tomography (PET)/computed tomography (CT) can improve imaging techniques in patients with breast…NCT05226663·St Louis, Missouri and 2 others

CompletedRandomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerTo compare the sequential administration of exemestane with administration of further tamoxifen until 5 years in postmenopausal women with operable breast cancer who have already…NCT00038467·Birmingham, Alabama and 376 others

CompletedLifestyle Intervention Study in Adjuvant Treatment of Early Breast CancerThe primary objective of this trial is to evaluate the effect of the addition of a 2 year, centrally delivered individualized, telephone-based lifestyle intervention focusing on…NCT00463489·Torrance, California and 20 others

UnknownPhase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast CancerRATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00499525·Muscle Shoals, Alabama and 42 others

Active not recruitingNiraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerThis phase IB trial evaluates the effect of niraparib and TSR-042 in treating patients with BRCA-mutated breast, pancreas, ovary, fallopian tube, or primary peritoneal cancer that…NCT04673448·Seattle, Washington

PreviousPage 22 of 63Next

Other Conditions in Washington

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma